Beximco Pharmaceuticals Ltd: A Leader in Bangladesh’s Pharmaceutical Industry
Beximco Pharmaceuticals Ltd, commonly known as Beximco Pharma, stands as a cornerstone of Bangladesh’s thriving pharmaceutical sector. Established in 1980, this company has grown from a modest distributor to a global generic pharma powerhouse, making significant strides in both domestic and international markets.
Headquartered at 19 Dhanmondi R/A, Road No. 7, Dhaka 1205, Bangladesh, Beximco Pharma boasts an impressive market share of 9.6% with a growth rate of 4.2%. The company’s extensive portfolio includes 399 generic products, cementing its position as a versatile and comprehensive pharmaceutical manufacturer.
Here are Beximco Pharmaceuticals Ltd classifications:
| Classification | Details |
|---|---|
| Company Name | Beximco Pharmaceuticals Ltd (Beximco Pharma) |
| Established | 1980 |
| Industry | Pharmaceutical |
| Type | Public Limited Company |
| Headquarters | 19 Dhanmondi R/A, Road No. 7, Dhaka 1205, Bangladesh |
| Market Share | 9.6% |
| Growth Rate | 4.2% |
| Total Generic Products | 399 |
| Number of Employees | Over 4,700 |
| Stock Listings | Dhaka Stock Exchange (DSE), Chittagong Stock Exchange (CSE), London Stock Exchange (AIM) |
| Major Operations | Manufacturing and exporting generic medicines |
| Export Destinations | Over 50 countries including USA, Europe, Canada, Australia |
| Key Certifications | USA FDA, UK MHRA, EU GMP, TGA Australia, Health Canada |
| Notable Awards | National Export Trophy (Gold) – 5 times, SCRIP Award, CPhI Pharma Award |
| Major Acquisitions | Nuvista Pharma (2018), Sanofi Bangladesh Limited (2021) |
| Key Product Categories | Analgesics, Cardiovascular, Gastroenterology, Respiratory, Endocrinology |
| Top Brands | Napa, Napa Extra, Bizoran, Atova, Acifix, Frenxit, Bexitrol F |
| Corporate Focus | High-quality generics at affordable prices |
| Contact Number | 880-2-58611001-7 |
| Fax | 880-2-58613888, +880-2-58614601 |
This table provides a comprehensive overview of Beximco Pharmaceuticals Ltd, highlighting its key characteristics, achievements, and operational details.
Beximco Pharma Company Overview
Beximco Pharma’s journey began in the late 1970s as a distributor for global pharmaceutical giants like Bayer and Upjohn. In 1980, the company transitioned to manufacturing under licensing arrangements, and by 1983, it had launched its own formulation brands. This strategic evolution set the foundation for Beximco’s future success.
Global Recognition and Certifications
Beximco Pharma’s commitment to quality has earned it certifications from regulatory authorities in the USA, Europe, Australia, Canada, Latin America, and South Africa. This global recognition has opened doors to over 50 export markets, including highly regulated ones like the USA and Europe.
The company’s excellence hasn’t gone unnoticed in the industry. Beximco Pharma has claimed the National Export Trophy (Gold) a record five times and remains the only Bangladeshi company to win the prestigious SCRIP Award for “Best Pharma Company in an Emerging Market.” In 2020, it also secured the CPhI Pharma Award for “Innovation in Response to COVID-19.”
Financial Milestones
Beximco Pharma’s financial acumen is evident in its listing on the AIM of the London Stock Exchange, making it the first and only Bangladeshi company to achieve this distinction. This listing has enhanced its global visibility and access to international capital markets.
Strategic Acquisitions
To strengthen its market position, Beximco Pharma has made strategic acquisitions:
- In 2018, it acquired a majority stake in Nuvista Pharma, a leading hormone and steroid manufacturer in Bangladesh.
- In 2021, the company expanded its portfolio by acquiring a 54.6% stake in Sanofi Bangladesh Limited, which was subsequently renamed Synovia Pharma PLC.
Workforce and Expertise
Beximco Pharma’s success is driven by its diverse and skilled workforce of over 4,700 employees. This team includes pharmacists, doctors, engineers, chemists, microbiologists, accountants, and business graduates, ensuring a multidisciplinary approach to pharmaceutical development and production.
Beximco Pharma Top Brands
Some of Beximco Pharma’s leading products include:
- Napa and Napa Extra (Paracetamol)
- Bizoran (Amlodipine Besilate + Olmesartan Medoxomil)
- Atova (Atorvastatin Calcium)
- Acifix (Rabeprazole Sodium)
- Frenxit (Flupentixol + Melitracen)
- Bexitrol F (Salmeterol + Fluticasone Propionate)
- Glipita-M (Sitagliptin + Metformin Hydrochloride)
- Amdocal (Amlodipine Besilate)
Corporate Philosophy
Beximco Pharma’s success is underpinned by its commitment to producing high-quality generics at affordable prices. The company’s mission extends beyond profit, focusing on improving access to quality medicines and contributing to better health outcomes in Bangladesh and beyond.
Future Outlook
With its strong market position, international recognition, and strategic growth initiatives, Beximco Pharmaceuticals Ltd is well-positioned to continue its upward trajectory. As the company expands its global footprint and invests in research and development, it’s poised to play an even more significant role in the global pharmaceutical landscape.
Conclusion
Beximco Pharmaceuticals Ltd exemplifies the potential of Bangladesh’s pharmaceutical industry. Through innovation, quality focus, and strategic expansion, the company has not only become a domestic leader but also a respected player in the global pharmaceutical market. As it continues to grow and evolve, Beximco Pharma remains committed to its core mission: providing affordable, high-quality medicines to improve lives around the world.
